|
Volumn 373, Issue 6510, 1995, Pages 117-122
|
Viral dynamics in human immunodeficiency virus type 1 infection
a a a a b b c d d a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIVIRUS AGENT;
INDINAVIR;
NEVIRAPINE;
PROTEINASE INHIBITOR;
RITONAVIR;
VIRUS RNA;
ARTICLE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG RESISTANCE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LIFESPAN;
NONHUMAN;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
VIRUS DETECTION;
VIRUS MUTANT;
VIRUS REPLICATION;
VIRUS RESISTANCE;
ANTIVIRAL AGENTS;
BASE SEQUENCE;
CD4 LYMPHOCYTE COUNT;
CD4-POSITIVE T-LYMPHOCYTES;
CELL SURVIVAL;
DNA, VIRAL;
DRUG RESISTANCE, MICROBIAL;
GENOTYPE;
HIV INFECTIONS;
HIV PROTEASE INHIBITORS;
HIV-1;
HIV-1 REVERSE TRANSCRIPTASE;
HUMANS;
LEUKOCYTES, MONONUCLEAR;
MOLECULAR SEQUENCE DATA;
MUTATION;
PHENOTYPE;
REVERSE TRANSCRIPTASE INHIBITORS;
RNA, VIRAL;
RNA-DIRECTED DNA POLYMERASE;
VIREMIA;
VIRUS REPLICATION;
HUMAN IMMUNODEFICIENCY VIRUS;
HUMAN IMMUNODEFICIENCY VIRUS 1;
|
EID: 0028811974
PISSN: 00280836
EISSN: None
Source Type: Journal
DOI: 10.1038/373117a0 Document Type: Article |
Times cited : (2958)
|
References (44)
|